Sign in
4

Changes in Ownership

Organogenesis Holdings Inc. Filed Acc 0001062993-23-004890

Chief Commercial Officer acquired 291,009 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Grow Brian Chief Commercial Officer 2023-02-22 Grant or award +291,009 374,608 D
Derivatives
Grow Brian Chief Commercial Officer 2023-02-22 Grant or award · Stock Option (Right to Buy) +345,470 345,470 D
Loading xslF345X03/form4.xml…